Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells

Leukemia Research

Volumn 30, Issue 11, 2006, Pages 1447-1451

  Gu, Chunhong ^a   Ye, Teng ^a   Wells, Richard A ^a,b,c  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

AML; Apoptosis; AraC; Chemotherapy; Daunorubicin; Etoposide; Leukaemia; Synergy

Indexed keywords

CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; ETOPOSIDE; TROGLITAZONE;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMANS; CYTARABINE; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ETOPOSIDE; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA, MYELOCYTIC, ACUTE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINEDIONES; U937 CELLS;

EID: 33748118943     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.029     Document Type: Article

References (9)

1. Claus R., Almstedt M., and Lubbert M. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol 32 5 (2005) 511-520
2. Schmidt-Arras D., et al. Flt3 receptor tyrosine kinase as a drug target in leukemia. Curr Pharm Des 10 16 (2004) 1867-1883
3. Yee K.W., et al. Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells. Blood 104 13 (2004) 4202-4209
4. Adjei A.A., et al. Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. Clin Cancer Res 7 5 (2001) 1438-1445
5. Kamel-Reid S., Zhang T., and Wells R.A. Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis. Oncogene 22 41 (2003) 6424-6435
6. Rothwell C., et al. Chronic toxicity in monkeys with the thiazolidinedione antidiabetic agent troglitazone. J Toxicol Sci 27 1 (2002) 35-47
7. Djazayeri K., et al. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment. Eur J Pharmacol 522 1-3 (2005) 122-129
8. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22 (1984) 27-55
9. Loi C.M., et al. Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites. J Clin Pharmacol 37 11 (1997) 1038-1047